Drug Information

Drug General Information
Drug ID
D0L1NS
Former ID
DNC012471
Drug Name
2-(4-Benzyl-piperazin-1-yl)-benzothiazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533917]
Structure
Download
2D MOL

3D MOL
Formula
C18H19N3S
Canonical SMILES
C1CN(CCN1CC2=CC=CC=C2)C3=NC4=CC=CC=C4S3
InChI
1S/C18H19N3S/c1-2-6-15(7-3-1)14-20-10-12-21(13-11-20)18-19-16-8-4-5-9-17(16)22-18/h1-9H,10-14H2
InChIKey
SNRZSONRAFJJSB-UHFFFAOYSA-N
PubChem Compound ID
1484933
Target and Pathway
Target(s) 5-hydroxy-tryptamine 3B receptor Target Info Inhibitor [533917]
5-hydroxytryptamine receptor 3A Target Info Inhibitor [533917]
KEGG Pathway Serotonergic synapsehsa04726:Serotonergic synapse
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway 5HT3 type receptor mediated signaling pathwayP04375:5HT3 type receptor mediated signaling pathway
Reactome Ligand-gated ion channel transportR-HSA-975298:Ligand-gated ion channel transport
WikiPathways Iron uptake and transportWP706:SIDS Susceptibility Pathways
Iron uptake and transport
References
Ref 533917J Med Chem. 1994 Apr 29;37(9):1320-5.Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
Ref 533917J Med Chem. 1994 Apr 29;37(9):1320-5.Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.